Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,137,033
+$34,277 QoQ
Shares Held
13,636
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#413
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOWE BROCKENBROUGH & CO INC holds $62,097,620 across 10 Drug Manufacturers - General names. NVS ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,660 | $12,104,210 | |
| 2 | MRK |
Merck & Co., Inc.
|
91,716 | $11,785,506 | |
| 3 | LLY |
ELI LILLY & Co
|
8,214 | $9,852,118 | |
| 4 | AMGN |
Amgen Inc
|
26,947 | $9,758,047 | |
| 5 | ABBV |
AbbVie Inc.
|
29,181 | $7,343,106 | |
| 6 | PFE |
Pfizer Inc
|
216,527 | $5,213,970 | |
| 7 | NVS |
Novartis AG
This page
|
13,636 | $2,137,033 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,635 | $1,880,428 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,137,033 | 13,636 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,102,756 | 13,766 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,946,448 | 14,118 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,840,115 | 14,349 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,758,759 | 14,534 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,618,912 | 14,522 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,434,641 | 14,743 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,766,822 | 15,361 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,556,338 | 14,619 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,467,297 | 15,169 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,644,801 | 16,290 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,624,157 | 15,945 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,655,832 | 16,409 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,547,716 | 16,823 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,541,423 | 16,991 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,293,006 | 17,011 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,421,541 | 16,817 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,628,552 | 18,559 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,736,716 | 19,855 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,642,060 | 20,079 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,768,869 | 19,387 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,644,207 | 19,235 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,801,535 | 19,078 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,681,545 | 19,337 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,764,966 | 20,208 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,728,811 | 20,968 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||